Summary. Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (< 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction.
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Studies of cell-mediated immunity in patients with Type 1 (insulin-dependent) diabetes at the time of clinical diagnosis have shown significant abnormalities of lymphocyte subpopulations including a reduced percentage of CD4 (helper/inducer) and CD8 (cytotoxic/suppressor) lymphocytes [1] . Lymphocytes possessing ClassII molecules and receptors for intefleukin-2 (IL-2r) have been detected in peripheral blood at the time of diagnosis [2] [3] and it is likely that these markers of activation reflect at peripheral level the autoimmune cell-mediated process known to take place in the pancreas against B cells.
There is now increasing evidence suggesting that the onset of Type 1 diabetes represents the final phase of a pathological event which began many years before. Specific immune disregulation occurs in this pre-clinical asymptomatic period and the presence of islet cell antibodies (ICA) [4] and of circulating activated T cells [5] has been reported in individuals genetically susceptible to the disease.
We report here the results of a five-year longitudinal investigation of lymphocyte subsets in a group of first degree relatives in our Bart's-Windsor Family Study, six of whom subsequently developed Type I diabetes.
Patients and methods
Family members: In 1983 a prospective study of cell-mediated immune parameters was started with the aim of evaluating peripheral lymphocyte subpopulations in unaffected members of families with at least one diabetic child. Fifty-six first degree relatives were regularly followed-up and blood taken at least twice a year for a period of 5 years. The total number of samples collected over this period was 386 and an equal number of tests (approximately 6 per subject) were performed over the period of follow-up.
The characteristics of relatives studied are listed in Table t . Of these, six individuals developed Type t diabetes in the course of follow-up.
Methods

Lymphocyte phenotyping
This was performed using a panel of internationally recognised monoclonal antibodies defining CD3 (UCHTt), CD4 (Leu 3a) and CD8 (UCHT4) lymphocytes subsets, CD7 (H25), total Ia+ cells (DA2) and CD25 (IL-2r-TAC) (all kindly donated by Dr. Peter Beverley, University College and Middlesex School of Medicine, London, UK). Cells were obtained from peripheral blood following Ficoll Hypaque (Pharmacia, Milton Keynes, UK) gradient centrifugation and stored in liquid nitrogen until required. Aliquots of 105 cells were in- cubated with 50 gl (working dilution) of the relevant antibody for 30 min at 4 ~ C, washed twice and incubated for 45 min at 4 ~ C with 50 lxl of a rabbit anti-mouse fluorescinated antiserum (Gibeo, Paisley, Scotland). Cells were washed three times in phosphate buffered saline (PBS) and 5 lxl of each labelled sample were dispensed in a well of a Hamax plate (Medicell International, London, UK). Fluorescent positive cells (at least 300) were counted on an inverted UV microscope. Intra-assay variation under these conditions is 1.5%.
Statistical analysis
Statistical analysis was made using the Mann Whitney U test.
Results
Overall analysis
Significant changes were observed with regard to the percentage of total T lymphocyte subpopulations in the three groups of 1st degree relatives compared to a group of 70 normal subjects without a family history of diabetes [6] ( Table 2 ). The most relevant change was the decrease of CD4 + cells (helper phenotype). As CD8 + cells were not different, the CD4/CD8 lymphocyte ratio was then significantly decreased in 1st degree relatives. When the presence of ICA was taken into account and correlated with abnormally low values of CD4/CD8 lymphocyte ratio (< 1.5), 69% of CF-ICA, 46% of ICA-IgG and 38% of ICA negative first degree relatives showed on at least three occasions this abnormal parameter. Total Ia+ lymphocytes (>15%) and IL-2+ cells (>5%) [51 were observed on one occasion in the majority of subjects independently of the presence or absence of ICA; IL-2r+ cells were detected on two occasions in five females and one male (3 CF-ICA, 2 ICA-IgG, 1 ICA negative) of whom one was HLA identical and five shared one HLA haplotype in common with the proband; total Ia + lymphocytes were also found on two occasions in five females and three males of whom two were HLA identical and six HLA haploidentical to the proband (2 CF-ICA, 1 ICA-IgG, 5 ICA negative). Only in two subjects (one female and one male) of whom one was CF-ICA, and the other ICA-IgG were the two markers of T cell activation present at the same time. Overall, conventional ICA+ individuals showed higher values of IL2r+ cells compared to subjects possessing CF-ICA (t7 < 0.03) ( Table 2) .
Finally, we did not observe any correlation between HLA phenotype and T-cell data in the three groups of 1st degree relatives.
Lymphocyte abnormalities in subjects who subsequently developed diabetes Other tests
All subjects were typed for HLA A, B, C antigens by standard microlymphocytotoxicity test and DR typed by soluble cell immunofluorescent tests; conventional ICA (ICA IgG) and the complement fixing subgroup (CF-ICA) were detected following the standard protocols distributed at the First International Workshop on the Standardisation of the ICA test. These specificities were assayed both at the time when the samples were collected for lymphocyte phenotyping and retested and titred during the subsequent stages of the ICA Standardisation Programme. In our laboratory, the coefficient of variation at 10 JDF units of the standard serum is 12%.
Six individuals (five males and one female, mean age 27 + 9 years) developed Type 1 diabetes in the course of the study. Five subjects had one HLA haplotype in common with the diabetic proband, one was HLA identical. The pattern of the CD4/CD8 ratio observed in these six individuals is illustrated in Figure 1 . It is worth noting that the CD4/CD8 lymphocyte ratio was persistently low in five out of six subjects before the onset of the disease. No other subjects showed such constant abnormality during the period of follow-up. Lymphocyte activation (high levels of Ia + and/or IL-2r+ cells) was found on two occasions in two of these subjects. No other cell-mediated immune abnormalities were detected. All six subjects were repeatedly CF-ICA positive before the onset of clinical symptoms.
Discussion
Evidence is presented here indicating that an imbalance of immunoregulatory lymphocyte subsets is present before the onset of Type 1 diabetes in subjects genetically susceptible to the disease. There appears to be a relationshiP between a reduced CD4/CD8 lymphocyte ratio (< 1.5) and the presence of ICA, in particular CF-ICA, thus suggesting that an abnormal cell mediated immune response may contribute to the final mechanisms leading to B-cell destruction. It is well recognised that a reduced CD4/CD8 lymphocyte ratio (in normal subjects values are between 1.5 and 2.5) is indicative of impairment of the cell mediated immune: response and subjects with such an imbalance have been Shown to be more susceptible to viral infections [7] . First degree relatives have all shown on some occasions, a CD4/CD8 lymphocyte ratio below 1.5, thus confirming that immune disturbance may be independent of diabetes risk. However, the persistence of the decreased lymphocyte ratio was typical only of those subjects who later became diabetic.
A long pre-diabetic phase is now a well recognised feature of Type 1 diabetes; it might be that this is due to a genetically determined lack of effective immune recognition of certain environmental stimuli leading to chronic viral infections which may hit B cells in the pancreas. A persistent reduction of the CD4/CD8 lymphocyte ratio might favour the spread of unrecognised silent infections. Indirect evidence to support this hypothesis comes from data obtained in patients with Type 1 diabetes following vaccination with hepatitis B virus. Surprisingly, and despite good metabolic control, 31% of patients did not show a significant rise of antibody titres to the virus and 19% had only a low titre [8] . These patients also showed a reduced CD4/CD8 lymphocyte ratio.
If this is the case, how do we explain the production of ICA when helper T lymphocyte number and possible function seems to be reduced in these individuals ? One possibility is that a subset within the T helper population, known to stimulate B lymphocyte proliferation [9] , may be responsible for the activation of autoreactive B lymphocytes (cells which are known to be less tolerant against self-antigens) to produce ICA.
It is not unexpected that only two out of six subjects who developed diabetes showed persistent lymphocyte activation in the peripheral blood. First of all, activated lymphocytes are mainly present in the area of the damaging process and they account for the majority of infiltrating lymphocytes in insulitis. Peripheral levels may rarely reflect the overspill. In this context it is of relevance that the lowest levels of circulating IL-2r + cells have been found in CF-ICA subjects. As previously reported [5, 10] high circulating levels of IL-2r + cells may occur only in certain phases of the final killing Process. Furthermore, it is interesting that lymphocytes with receptors for IL-2 have been observed very rarely during the pre-diabetic follow-up period and, if more than once, only in subjects with ICA in particular thos e with conventional ICA. In accordance with Hitchcock et al. [10] the low percentage of lymphocytes with IL-2 receptors in CF-ICA+ pre-diabetic subjects could reflect an ongoing chronic rather than acute type of autoimmune process towards B cells.
In conclusion, these results extend the observation that cell-mediated immune parameters may be found impaired in peripheral blood before the onset of Type 1 diabetes in susceptible individuals [5] . New impetus should now be given to investigate the mechanisms of "no return" in subjects genetically at risk but with persistant immune abnormalities. Functional studies of lymphocyte subsets in these individuals are bound to spread light to this important aspect of the pre-diabetic period.
